Technical Analysis for NKGN - NKGen Biotech, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 20 DMA | Bullish | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Narrow Range Bar | Range Contraction | 7.97% | |
Inside Day | Range Contraction | 7.97% | |
Wide Bands | Range Expansion | 7.97% | |
20 DMA Resistance | Bearish | 5.21% | |
Pocket Pivot | Bullish Swing Setup | 5.21% | |
Volume Surge | Other | 5.21% | |
Wide Bands | Range Expansion | 5.21% | |
Narrow Range Bar | Range Contraction | 18.61% |
Alert | Time |
---|---|
Rose Above 20 DMA | about 16 hours ago |
Rose Above Previous Day's High | about 16 hours ago |
Down 3% | about 16 hours ago |
Up 5% | about 16 hours ago |
Up 3% | about 16 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2024
NKGen Biotech, Inc. operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. It develops SNK01, an autologous NK cell therapy; and SNK02, an allogeneic NK cell therapy, which are in Phase 1 clinical trials. The company was founded in 2017 and is based in Santa Ana, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immune System Stem Cell Cell Therapy Cell Biology Natural Killer Cell Lymphocytes
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immune System Stem Cell Cell Therapy Cell Biology Natural Killer Cell Lymphocytes
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.06 |
52 Week Low | 0.2026 |
Average Volume | 1,488,822 |
200-Day Moving Average | 1.07 |
50-Day Moving Average | 0.37 |
20-Day Moving Average | 0.29 |
10-Day Moving Average | 0.28 |
Average True Range | 0.05 |
RSI (14) | 48.98 |
ADX | 28.7 |
+DI | 33.09 |
-DI | 17.91 |
Chandelier Exit (Long, 3 ATRs) | 0.28 |
Chandelier Exit (Short, 3 ATRs) | 0.40 |
Upper Bollinger Bands | 0.37 |
Lower Bollinger Band | 0.21 |
Percent B (%b) | 0.63 |
BandWidth | 56.79 |
MACD Line | -0.03 |
MACD Signal Line | -0.04 |
MACD Histogram | 0.0116 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.37 | ||||
Resistance 3 (R3) | 0.37 | 0.34 | 0.36 | ||
Resistance 2 (R2) | 0.34 | 0.33 | 0.35 | 0.36 | |
Resistance 1 (R1) | 0.33 | 0.32 | 0.34 | 0.33 | 0.36 |
Pivot Point | 0.30 | 0.30 | 0.31 | 0.31 | 0.30 |
Support 1 (S1) | 0.29 | 0.29 | 0.29 | 0.29 | 0.27 |
Support 2 (S2) | 0.26 | 0.28 | 0.26 | 0.26 | |
Support 3 (S3) | 0.25 | 0.26 | 0.26 | ||
Support 4 (S4) | 0.25 |